Michael acceptor containing drugs are a novel class of 5-lipoxygenase inhibitor targeting the surface cysteines C416 and C418

Autor: Maucher, Isabelle V., Rühl, Michael, Kretschmer, Simon B.M., Hofmann, Bettina, Kühn, Benjamin, Fettel, Jasmin, Vogel, Anja, Flügel, Karsten T., Manolikakes, Georg, Hellmuth, Nadine, Häfner, Ann-Kathrin, Golghalyani, Vahid, Ball, Ann-Katrin, Piesche, Matthias, Matrone, Carmela, Geisslinger, Gerd, Parnham, Michael J., Karas, Michael, Steinhilber, Dieter, Roos, Jessica, Maier, Thorsten J.
Zdroj: In Biochemical Pharmacology 1 February 2017 125:55-74
Databáze: ScienceDirect
Externí odkaz: